Identification and Characterization of Fenofibrate-Induced Liver Injury.

about

Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial.

P2860

Q52599940-03075F04-BB14-4CBF-A474-9A7E3766991C

P2860

Identification and Characterization of Fenofibrate-Induced Liver Injury.

Item

http://www.wikidata.org/entity/Q47422605

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Identification and Characterization of Fenofibrate-Induced Liver Injury.

@en

Identification and Characterization of Fenofibrate-Induced Liver Injury.

@nl

type

Item

label

Identification and Characterization of Fenofibrate-Induced Liver Injury.

@en

Identification and Characterization of Fenofibrate-Induced Liver Injury.

@nl

prefLabel

Identification and Characterization of Fenofibrate-Induced Liver Injury.

@en

Identification and Characterization of Fenofibrate-Induced Liver Injury.

@nl

P1476

Identification and Characterization of Fenofibrate-Induced Liver Injury.

@en

P2093

David E Kleiner

http://www.w3.org/2001/XMLSchema#string

Elizabeth T Cirulli

http://www.w3.org/2001/XMLSchema#string

Huiman Barnhart

http://www.w3.org/2001/XMLSchema#string

Jay H Hoofnagle

http://www.w3.org/2001/XMLSchema#string

Joseph A Odin

http://www.w3.org/2001/XMLSchema#string

Naga Chalasani

http://www.w3.org/2001/XMLSchema#string

Paul H Hayashi

http://www.w3.org/2001/XMLSchema#string

Robert J Fontana

http://www.w3.org/2001/XMLSchema#string

P2860

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

Prolonged cholestasis after raloxifene and fenofibrate interaction: A case report

Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network

Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method

Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.

Use of fibrates in the United States and Canada

Peroxisome proliferator-activated receptor alpha induction of uncoupling protein 2 protects against acetaminophen-induced liver toxicity.

Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury.

Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct.

P2888

s10620-017-4812-7

P304

3596-3604

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10620-017-4812-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jawad Ahmad

P577

2017-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29119413

http://www.w3.org/2001/XMLSchema#string

P932

5694705

http://www.w3.org/2001/XMLSchema#string

Identification and Characterization of Fenofibrate-Induced Liver Injury.

about

P2860

P2860

Identification and Characterization of Fenofibrate-Induced Liver Injury.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P932